Medicine and HealthNature Communications
An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing
K. H. Ooi, M. M. Liu, et al.
Discover a groundbreaking CRISPR-based diagnostic assay developed by Kean Hean Ooi, Mengying Mandy Liu, Jie Wen Douglas Tay, Seok Yee Teo, Pornchai Kaewsapsak, Shengyang Jin, Chun Kiat Lee, Jingwen Hou, Sebastian Maurer-Stroh, Weisi Lin, Benedict Yan, Gabriel Yan, Yong-Gui Gao, and Meng How Tan that provides rapid results in just 30 minutes, maintaining 100% specificity and sensitivity. This robust innovation could change the landscape of COVID-19 testing!
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
X. Xie, A. E. Muruato, et al.
Medicine and Health
COVID-19 Public Health Measures and Patient and Public Involvement in Health and Social Care Research: An Umbrella Review
N. Fouladi, N. Tchangalova, et al.
Medicine and Health
Social determinants of health and COVID-19: An evaluation of racial and ethnic disparities in attitudes, practices, and mental health
J. R. Patel, C. C. Brown, et al.
Environmental Studies and Forestry
Promoting economic and environmental resilience in the post-COVID-19 era through the city and regional on-road fuel sustainability development
C. Yang, H. Wu, et al.
